Latent Labs
AI protein design / techbio, London
Frontier AI models for designing novel proteins and programmable biology. It raised $40m in its Series A in February 2025. It has 7 roles open, 4 of them in the UK.
Backed by 8VC, Kindred Capital, Radical Ventures and Sofinnova Partners. Total raised ~$50m.
On the Home Office register of licensed visa sponsors.
- 255 daystypical age of an open role
- 7roles open for more than 60 days
- 3roles taken down since we started tracking
- 0%of roles list a salary
Open roles
7 live todayOpen roles over time
Hiring momentum
Roles per weekAdded (by posting date)Closed (removed from the board)
Open roles by function
Open roles by team
As the company labels themIn the news
All 9 stories- ProductSynBioBeta, 21 Jul 2026Latent Labs Unveils Latent-Y: A Revolutionary Drug Design Tool for Researchers
- ProductBusiness Wire, 15 Jul 2026Latent Labs Launches Latent-Y to Researchers Worldwide — With Free Daily Access and On-Demand Credits for Larger Campaigns
- OtherSynBioBeta, 1 May 2026Inside Latent Labs’ Autonomous Drug Design Engine
- Otherbiocentury.com, 6 Feb 2026Latent Labs: AI-designed, ready-to-develop biologics
- OtherBusiness Wire, 16 Dec 2025Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity
- Otherobserver.com, 10 Oct 2025Latent Labs’ Simon Kohl Is Rewriting the Code of Biology With Generative A.I.